Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 20.2 CHF -5.61%
Market Cap: CHf116.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+14%
5Y
+237%
10Y
-
Liabilities
+
3Y
-11%
5Y
+311%
10Y
-
Equity
+
3Y
+44%
5Y
+196%
10Y
-

Balance Sheet Decomposition
Xlife Sciences AG

Balance Sheet
Xlife Sciences AG

Rotate your device to view
Balance Sheet
Currency: CHF
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
3
5
2
0
0
0
Cash Equivalents
3
5
2
0
0
0
Total Receivables
2
0
0
1
18
14
Accounts Receivables
2
0
0
1
9
8
Other Receivables
0
0
0
0
9
6
Inventory
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
Total Current Assets
5
5
2
1
18
14
PP&E Net
0
0
1
1
0
0
PP&E Gross
0
0
1
1
0
0
Accumulated Depreciation
0
0
0
0
0
1
Intangible Assets
0
0
317
301
285
269
Goodwill
0
0
0
0
0
0
Long-Term Investments
149
180
160
188
208
252
Other Long-Term Assets
0
0
0
0
0
4
Other Assets
0
0
0
0
0
0
Total Assets
154
N/A
186
+21%
480
+159%
490
+2%
512
+4%
540
+6%
Liabilities
Accounts Payable
0
0
0
1
1
1
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
1
5
Other Current Liabilities
0
3
2
1
4
3
Total Current Liabilities
1
3
2
2
6
9
Long-Term Debt
56
52
63
61
56
54
Deferred Income Tax
0
0
95
90
85
81
Minority Interest
0
0
108
102
97
91
Other Liabilities
0
0
0
0
0
0
Total Liabilities
57
N/A
56
-2%
269
+384%
255
-5%
244
-4%
235
-4%
Equity
Common Stock
4
4
5
5
6
6
Retained Earnings
94
126
206
230
251
288
Other Equity
0
0
0
0
11
12
Total Equity
97
N/A
130
+34%
211
+62%
235
+11%
268
+14%
305
+14%
Total Liabilities & Equity
154
N/A
186
+21%
480
+159%
490
+2%
512
+4%
540
+6%
Shares Outstanding
Common Shares Outstanding
4
4
5
5
6
6

See Also

Summary
XLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
XLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XLS stock valuation using valuation multiples.
Wall Street Estimates
XLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.